BILCARE LTD.-$

Bilcare Ltd has clarified that despite an earlier board decision to appoint Mr. Mohan Bhandari as Executive Director and reappoint Ms. Kavita Bhansali as Executive Director, both resolutions failed to pass the requisite majority at the 39th Annual General Meeting. Consequently, Mr. Bhandari will continue as Non-Executive Non-Independent Director & CEO, and Ms. Bhansali will continue as Non-Executive Non-Independent Director.

Bilcare Ltd held its 39th Annual General Meeting (AGM) on September 26, 2026, through video conferencing. The company submitted the voting results and scrutinizers' reports as per SEBI regulations. All resolutions, including the adoption of financial statements and re-appointment/appointment of directors, were passed with overwhelming support. Shareholders demonstrated strong confidence in the company's financial health and leadership.

Bilcare Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The window will be shut from October 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half-year ended September 30, 2026. All designated persons are prohibited from trading during this period. The date for the Board of Directors' meeting to approve these financial results will be communicated separately.

Bilcare Limited has issued a corrigendum to the notice of its 39th Annual General Meeting (AGM), scheduled for September 26, 2026. The correction addresses an inadvertent clerical error in Item No. 4, which pertains to the appointment of Mr. Mohan Bhandari as a Director. The notice had mistakenly classified this as a 'Special Resolution' when it should be an 'Ordinary Resolution' as per the Companies Act, 2013. The company is rectifying this to ensure it is read as an Ordinary Resolution, with the resolution text and explanatory statement remaining unchanged. Bilcare is taking steps to communicate this correction to its members for voting purposes.

Bilcare Limited has issued a corrigendum to the notice of its 39th Annual General Meeting (AGM), scheduled for September 26, 2026. The correction pertains to Item No. 4, concerning the appointment of Mr. Mohan Bhandari as a Director. It was inadvertently stated as a 'Special Resolution' in the original notice, but it should be an 'Ordinary Resolution' as per the Companies Act, 2013. The company is rectifying this clerical error and ensuring members are informed for voting purposes. The resolution text and explanatory statement remain unchanged.

Bilcare Limited has received a disclosure under SEBI SAST Regulations, 2011, detailing changes in shareholding by Guttikonda Anuradha and associated persons. Guttikonda Vara Lakshmi's stake increased from 12.27% to 13.59%, and Guttikonda Rajasekhar's stake rose from 2.05% to 2.74%. Guttikonda Anuradha's holding remained at 0.14%. The changes occurred via open market transactions on September 17, 2026. The total equity share capital remains unchanged at ₹23,54,52,310/-.

Bilcare Limited has submitted its Annual Report for the Financial Year 2025-26 and the Notice for its 39th Annual General Meeting (AGM) scheduled for September 26, 2026. The AGM will be conducted via Video Conference (VC)/Other Audio-Visual Means (OAVM). The Board of Directors, in a meeting on September 4, 2026, approved modifications to the tenure of Executive Directors Mr. Mohan Bhandari and Ms. Kavita Bhansali, reducing their terms from 5 years to 3 years, subject to member approval. The company will provide electronic access to the Annual Report and AGM Notice to shareholders, with a cut-off date of September 18, 2026, for voting eligibility. Remote e-voting will be open from September 23 to September 25, 2026.

Bilcare Limited has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Guttikonda Rajasekhar and Persons Acting in Concert (PACs) including Guttikonda Anuradha and Guttikonda Vara Lakshmi. The disclosure details a change in shareholding consequent upon the disposal of shares. Prior to the disposal, the combined holding of the acquirers was 17.07% of the total diluted share capital. Following the sale of 2.64% of the total share capital (amounting to 6,15,180 shares for ₹23.54 Crores), their post-disposal holding is reduced. Guttikonda Vara Lakshmi now holds 12.27% and Guttikonda Rajasekhar holds 2.05%.

Bilcare Limited announced its Standalone & Consolidated Unaudited Financial Results for the quarter ended June 30, 2026. The Board of Directors approved these results, along with a Limited Review Report from the Statutory Auditors, at a meeting held on August 13, 2026. The company also approved the appointment of Mr. Mohan Bhandari as Executive Director and the reappointment of Ms. Kavita Bhansali as Executive Director. Additionally, Mr. Sagar R. Baheti resigned as Company Secretary and Compliance Officer, and Mr. Mayur Dave was appointed to these roles. The Board also approved the voluntary winding up of Bilcare INC, a non-material wholly owned subsidiary in the USA.

Bilcare Limited announced significant board changes following a meeting on August 13, 2026. Mr. Mohan Bhandari has been appointed as an Executive Director, subject to member approval. Ms. Kavita Bhansali has been reappointed as an Executive Director for a further five-year term, also pending member approval. The company also reported its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations at ₹1.94 Crores. Additionally, Mr. Sagar R. Baheti resigned as Company Secretary and Compliance Officer, with Mr. Mayur Dave appointed to these roles. The company also proposed the voluntary winding up of its wholly-owned US subsidiary, Bilcare INC, which is not considered a material subsidiary.